BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Prognosis
388 results:

  • 1. [Interpretation of the pathological diagnostic criteria and characteristics of high-grade thyroid follicular-derived carcinoma in the 5
    Zhou J; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1578-1583. PubMed ID: 38742344
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
    Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
    BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms.
    Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
    Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
    Wang H; Zhang C; Li Q; Tian T; Huang R; Qiu J; Tian R
    BMC Cancer; 2024 Apr; 24(1):427. PubMed ID: 38589799
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ata initial and dynamic risk assessment.
    Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
    Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
    Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer.
    Han PZ; Ye WD; Yu PC; Tan LC; Shi X; Chen XF; He C; Hu JQ; Wei WJ; Lu ZW; Qu N; Wang Y; Ji QH; Ji DM; Wang YL
    JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38478516
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis.
    Guo H; Lin H
    BMC Surg; 2024 Mar; 24(1):79. PubMed ID: 38438944
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Second radioiodine treatment in patients with differentiated thyroid carcinoma: Causes and effects.
    Sicilia Pozo MLN; Pena Pardo FJ; Amo Salas M; Cruz Montijano M; Torres Hernández J; Padilla Bermejo A; Montalbán Méndez C; Zhao Montero M; Soriano Castrejón Á; García Vicente AM
    Endocrinol Diabetes Nutr (Engl Ed); 2024 Jan; 71(1):4-11. PubMed ID: 38388076
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of the correlation of neutrophil/lymphocyte ratio with prognostic classification systems in papillary thyroid carcinoma patients.
    Yildiz EO; Işcen K; Kaya F; Güney OA; Ulukent SC
    Medicine (Baltimore); 2024 Feb; 103(5):e37210. PubMed ID: 38306518
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Progress in diagnosing and treating thyroid squamous cell carcinoma under the 5th edition of WHO classification.
    Ding W; Gao X; Ran X
    Front Endocrinol (Lausanne); 2023; 14():1273472. PubMed ID: 38303977
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating immunophenotypes are potentially prognostic in follicular cell-derived thyroid cancer.
    Kotwal A; Gustafson MP; Bornschlegl S; Dietz AB; Delivanis D; Ryder M
    Front Immunol; 2023; 14():1325343. PubMed ID: 38235146
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
    Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
    Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer.
    Kim JH; Kim SI; Park EY; Kim ET; Kim H; Kim S; Park SY; Lim MC
    Gynecol Oncol; 2024 Feb; 181():33-39. PubMed ID: 38104527
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association Between a History of Breast cancer and Decreased Thyroid cancer-specific Mortality.
    Lin S; Wang Z; Xing M
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2.
    Gong Z; Xue L; Vlantis AC; van Hasselt CA; Chan JYK; Fang J; Wang R; Yang Y; Li D; Zeng X; Tong MCF; Chen GG
    J Endocrinol Invest; 2024 May; 47(5):1271-1280. PubMed ID: 38062319
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. LncRNA H19 Influences Cellular Activities via the miR-454-3p/BHLHE40 Axis in Anaplastic Thyroid Carcinoma.
    Wu Y; Yang J; Zhang H; Cheng J; Lei P; Huang J
    Horm Metab Res; 2024 May; 56(5):392-399. PubMed ID: 38052232
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
    Xu T; Zhu C; Song F; Zhang W; Yuan M; Pan Z; Huang P
    BMC Cancer; 2023 Nov; 23(1):1131. PubMed ID: 37990304
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High overall copy number variation burden by genome-wide methylation profiling holds negative prognostic value in surgically treated pancreatic ductal adenocarcinoma.
    Detlefsen S; Boldt HB; Burton M; Thomsen MM; Rasmussen LG; Ørbeck SV; Pfeiffer P; Mortensen MB; de Stricker K
    Hum Pathol; 2023 Dec; 142():68-80. PubMed ID: 37977512
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
    Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
    J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 20.